| Name: |
|
| Other Names: |
|
|
Classification:
|
|
|
Mechanism of Action:
|
- Stimulates alpha and beta receptors, primarily alpha
- + inotrope
- + Chronotrope
- Increases coronary artery blood flow
- Causes severe vasoconstriction (increasing SVR)
|
|
Indications:
|
- Septic shock
- Neurogenic shock
- Cardiogenic shock
|
|
Contraindications:
|
- Hypovolemia (hemorrhage, dehydration)
|
|
Precautions:
|
- Monitor BP every 2 - 5 min until stable
- Monitor Urinary Output
- Monitor IV site carefully, extravasations can cause necrosis, notify receiving
- Monitor perfusion of extremities
- Use cautiously in patients with cardiac history
- Use cautiously in the elderly
- Use cautiously in patients with hyperthyroidism
|
|
Adverse Effects:
|
- May increase myocardial ischemia
|
|
Dose:
|
- Mix 8 mg in 250 ml bag of D5W
- Initiate an infusion via infusion pump at 0.05 to 0.1 mcg/kg/min. Adjust infusion rate in increments of 0.05 to 0.1 mcg/kg/min as frequently as q1-5 min to achieve/maintain target blood pressure. The usual max dose is 1 mcg/kg/min.
|
| Routes: |
|
| Special Notes: |
- Norepinephrine must be given through an infusion pump.
- Most shock states require fluid administration prior to vasopressors therefore normal saline should be initiated prior to norepinephrine administration.
- It is recommended to administer a normal saline infusion by gravity with any norepinephrine infusion. To do this:
- Initiate a normal saline infusion at a rate appropriate to patient condition via gravity (i.e., not through the pump)
- Connect the norepinephrine infusion (via the pump) to the access port of the normal saline infusion line proximal to the patient
- This will help as a driver when volumes of medication being infused are small
- Focus on fluid administration in patients with hypovolemic shock.
- Epinephrine is the vasopressor of choice within the EHS ground ambulance system for pediatric patients ≤ 16 years of age.
- May cause fetal anoxia when used in pregnancy.
- Pregnancy category D [potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g., if it is required in a life-threatening situation)]
|
| References: |
- Compendium of Pharmaceuticals and Specialties (CPS)
- Pharmacology for the Prehospital Provider 2nd Edition
|
Last modified: Wednesday, 26 March 2025, 4:30 PM